Related references
Note: Only part of the references are listed.10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study
Yongze Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Sandeep R. Das et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Standards of medical care for type 2 diabetes in China 2019
Weiping Jia et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Alexander Vonbank et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2018)
Type 2 diabetes epidemic in East Asia: a 35–year systematic trend analysis
Huiping Yuan et al.
Oncotarget (2017)
Diabetes medication persistence, different medications have different persistence rates
Michal Shani et al.
PRIMARY CARE DIABETES (2017)
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Rury R. Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study)
Jin Du et al.
DIABETES OBESITY & METABOLISM (2017)
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes
Ginger S. Carls et al.
DIABETES CARE (2017)
Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin
Ping-I Hsu et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015 —EXECUTIVE SUMMARY
Yehuda Handelsman et al.
Endocrine Practice (2015)
Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database
Jianping Weng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: Results of two 6-month, phase 3 studies
David J. Whellan et al.
AMERICAN HEART JOURNAL (2014)
A Multinational, Observational Study to Investigate the Efficacy, Safety and Tolerability of Acarbose as Add-On or Monotherapy in a Range of Patients: The GlucoVIP Study
Weiwei Zhang et al.
CLINICAL DRUG INVESTIGATION (2013)
Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes
Jun-Sing Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Patient and Physician Factors Associated With Adherence to Diabetes Medications
Antoinette M. Schoenthaler et al.
DIABETES EDUCATOR (2012)
International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus
Chunlin Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment A Retrospective Cohort Study
Hein A. W. van Onzenoort et al.
HYPERTENSION (2011)
Cardiovascular Outcomes in Framingham Participants With Diabetes The Importance of Blood Pressure
Guanmin Chen et al.
HYPERTENSION (2011)
Patient adherence to medication requirements for therapy of type 2 diabetes
C. J. Bailey et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
Michael F. Pollack et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial
C. Pan et al.
DIABETIC MEDICINE (2008)
Type 2 diabetes as a coronary heart disease equivalent -: An 18-year prospective population-based study in Finnish subjects
A Juutilainen et al.
DIABETES CARE (2005)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
